Macter International Rolls Out TirzaTrim for Diabetes Management
Macter International Limited (PSX: MACTER) has successfully launched TirzaTrim (Tirzepatide), a next-generation treatment for Type 2 Diabetes Mellitus, in a multi-dose pre-filled…
Macter International Limited (PSX: MACTER) has successfully launched TirzaTrim (Tirzepatide), a next-generation treatment for Type 2 Diabetes Mellitus, in a multi-dose pre-filled…